XML 30 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 287,087 $ 221,859
Restricted cash, current 777 777
Accounts receivable, net 34,622 15,272
Inventory 42,201 28,543
Prepaid expenses and other current assets 3,981 6,175
Total current assets 368,668 272,626
Restricted cash 3,038 3,038
Property and equipment, net 27,032 8,656
Operating lease right-of-use assets, net 20,699 23,481
Intangible assets, net 1,273 1,477
Other assets 415 51
Total assets 421,125 309,329
Current liabilities:    
Accounts payable 13,597 9,391
Accrued compensation 13,265 13,447
Deferred revenue, current 5,007 2,855
Operating lease, current 1,702 2,129
Other current liabilities 7,785 7,468
Total current liabilities 41,356 35,290
Long-term debt 51,307 51,213
Operating lease, non-current 26,730 23,975
Loan facility derivative liability 1,859 1,779
Deferred revenue, non-current 517 0
Total liabilities 121,769 112,257
Commitments and contingencies (see Note 12)
Stockholders’ equity:    
Preferred stock, $0.00001 par value; Authorized shares: 10,000 at June 30, 2023 and December 31, 2022, Issued and outstanding shares: none at June 30, 2023 and December 31, 2022 0 0
Common stock, $0.00001 par value; Authorized shares: 300,000 at June 30, 2023 and December 31, 2022, Issued and outstanding shares: 45,000 and 44,828 at June 30, 2023 and December 31, 2022, respectively 0 0
Additional paid-in capital 726,428 545,753
Accumulated other comprehensive loss (6) (6)
Accumulated deficit (427,066) (348,675)
Total stockholders’ equity 299,356 197,072
Total liabilities and stockholders’ equity $ 421,125 $ 309,329